Searched for
BIOCON Q3
From Adani Green to Tata Tech: 50 companies swing back to profit in Q4 despite market turmoilIndian companies show strong recovery. Over 50 firms moved from losses to profits in the March quarter. This turnaround happened despite ma...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Stocks in news: BSE, Britannia, Paytm, Meesho, RILIndian markets showed resilience, climbing despite volatility, buoyed by positive global trends and falling crude oil prices. Analysts anti...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 croreBiocon shares: The board approved a hike in the company’s authorised share capital from Rs 625 crore to Rs 700 crore, along with a correspo...
- Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiaryBiocon share price: Biocon reported a 96% year-on-year (YoY) decline in net profit, which fell to Rs 25 crore in Q3FY25. In comparison, the...
- Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is...
- Syngene Q3 Results: Net profit rose 18% YoY to Rs 131 croreSyngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects single-digit r...
- Biocon Q3 Results: PAT at Rs 660 crore vs Rs 42-crore loss a year agoThe company said the revenue growth was supported by income from the divesture of two non-core business assets of Biocon Biologics' branded...
- Biocon Q4 Results: Net profit jumps 31% on strong biosimilar business growthIndian biopharmaceutical company Biocon posted a 31% year-on-year rise in Q4 FY23 net profit, at INR313 crore ($41.9m), driven by successfu...
- Biocon reports Rs 42 crore net loss in Q3 due to exceptional itemThe biggest contribution came from the biosimilars business, which reported a 54% increase in revenues to Rs 1,507 crore. Research Services...
- Biocon Q3 Results: Firm posts Rs 42 cr loss on one-time exceptional itemThe profit was also impacted due to dilution of Biocon’s stake in Biocon Biologics and Syngene. Net profit for the quarter, excluding an ex...
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...
- Biocon Q3 results: Net profit falls 19% to Rs 186.6 croreThe company's revenue from operations rose to Rs 1,851 crore for the quarter under consideration, up 7.81 per cent, as against Rs 1,716.8 c...
- Biocon Q3 profit dips 7% on R&D cost, tax impact; topline jumps 14%Biocon’s profit before exceptional item at Rs 225 crore reported a 6% growth. It reported an operating margin (EBITDA) of 27%.
- Biocon Q3 profit zooms twofold to Rs 217 croreConsolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore.
- Biocon Q3 net up 9 pc at Rs 93 croreNet sales of the company rose to Rs 634.22 crore for the third quarter, as against Rs 516.59 crore during the same period of 2011-12 fiscal.
- Biocon's Q3 net profit dips by 15.78% to Rs 84.85 croreThe Bangalore-based firm gave up 70% of its stake in Axicorp last April for a consideration of 40 million euros to the original promoters.
Load More
